Australian Patent Journal Round-Up 18 July – 5 September 2013

An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 11 July – 5 September 2013.

If you wish to oppose the grant of a patent, or if your grant own application has been opposed by third parties, please contact us.

Please note that the information in the tables below is correct as at the date of the Patent Office Journal but is subject to change.  Please check AUSPAT for the current status of any of the patents below.

Opposition Proceedings

Opposition Lodged

Acceptance of the following patent applications has been opposed:

Application No. Title Applicant(s) Opponent(s)
2008267367 Security Element Giesecke & Devrient GmbH Crane & Co., Inc.
2009314512 Lenalidomide solvates and processes Dr. Reddy’s Laboratories Ltd.; Dr. Reddy’s Laboratories,Inc. Celgene Corporation
2008234400 Mounting of wear members CQMS Pty Ltd Esco Corporation
2011211462 Improved process for the culturing of cells DSM IP Assets B.V. Refine Technology, LLC
2008315842 Sheet having at least one watermark or pseudo-watermark observable only on one side of the sheet Arjowiggins Security Innovia Security Pty Ltd
2009214744 Wood preservative composition Arch Wood Protection, Inc. Osmose New ZealandLimited
2010201836 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment Novartis AG Alphapharm Pty Ltd
2010201836 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment Novartis AG Apotex Pty Ltd
2010237067 Insecticidal composition and method ZELAM LIMITED Osmose New Zealand Limited
2007325316 IL-17A/F heterodimeric polypeptides and therapeutic uses thereof GENENTECH, INC. Amgen Inc
2007341700 Safety element having an optically variable element Giesecke & Devrient GmbH Innovia Security Pty Ltd
2008277472 Security device and method De La Rue International Limited Innovia Security Pty Ltd
2013201494 A Digital Advertising System and Method Rockt Pte Ltd Treanor, M.
2007270922 Security device De La Rue International Limited Innovia Security Pty Ltd
2008234401 A mounting pin assembly for an excavator wear member CQMS Pty Ltd ESCO Corporation
2010330673 A lock assembly for an excavator wear member CQMS Pty Ltd ESCO Corporation
2012214277 Expandable and contractible hose BLUE GENTIAN, LLC International Edge, Inc

Opposition Withdrawn

Opposition to acceptance of the following applications have been withdrawn:

Application No. Title Applicant(s) Opponent(s)
2007284549 Ground engaging tool system Caterpillar Inc. CQMS Pty Ltd
2008202834 Wear assembly for the digging edge of an excavator ESCO Corporation CQMS Pty Ltd
2004203235 Method for inhibiting corrosion of metal Canadian Auto Preservation Inc. Dynamco Pty Ltd
2004236650 Wear assembly for the digging edge of an excavator ESCO Corporation CQMS Pty Ltd
2009206484 Dragline bucket, rigging and system Esco Corporation CQMS Pty Ltd
2009272889 Two stage process for producing purified gas Shell Internationale Research Maatschappij B.V. ExxonMobil Upstream
2007266879 Improvements in substrates De La Rue International Limited Innovia Security Pty Ltd
2009200787 Transport and storage container for liquids Protechna S.A. VIP Steel Packaging Pty Ltd
2012202134 Anti-TNF antibodies and methotrexate in the treatment of autoimmune disease The Kennedy Institute of Rheumatology Celltrion, Inc.
2006326388 Compositions and methods for treating dermatological conditions Nuvo Research Inc. Apotex Pty Ltd
2007202390 Coupling for excavating wear part Esco Corporation CQMS Pty Ltd
2009344269 Method for the treatment of mixed hydroxide product produced in a metal extraction process Enfin Nickel Pty Ltd First Quantum Minerals Limited
2006284993 Wear assembly for excavating machines ESCO Corporation CQMS Pty Ltd
2007203396 Deformable/inflatable wear liner Rio Tinto Alcan International Limited BHP Billiton Iron Ore Pty Ltd

Opposition Dismissed

No opposition proceedings have been dismissed.

Applications Withdrawn

No additional Applications for Opposition have been withdrawn.

Application No. Title Applicant(s) Opponent(s)
2005221890 Protein DuPont Nutrition BioSciences ApS Novozymes A/ S
2005258206 Calorie reduction-taste retention food products Holzer, D.; Holzer, S. MGP Ingredients, Inc.

Extensions of Term of Standard Patents

Applications Filed

The following application(s) for Extension of Term under Section 70 have been made:

Patent No Title Patentee(s) First Reg Approval Date & Goods
784045 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies Genentech Inc. PERJETA pertuzumab
2008261137 Antibodies to OPGL Amgen Inc.; Amgen Fremont Inc. Jun 2010 2013    PROLIA denosumab
2009217435 Xanthine derivative, production and use thereof as a medicament Boehringer Ingelheim Pharma GmbH & Co. KG Nov 2011 2013    TRAJENTA linagliptin
2004251647 Abuse resistant amphetamine compounds Shire LLC 22 Jul 2013        VYVANSE lisdexamfetamine dimesilate
2005287404 HER2 antibody composition Genentech, Inc. 06 May 2013       PERJETA pertuzumab
2005295394 Antibody formulation in histidine-acetate buffer Genentech, Inc. 06 May 2013        PERJETA pertuzumab
2005244650 Pharmaceutical compositions comprising ZD6474 AstraZeneca AB 31 Jan 2013        CAPRELSA vandetanib
2003302029 4-oxoquinoline compound and utilization thereof as HIV integrase inhibitor Japan Tobacco Inc. 22 Feb 2013        STRIBILD tenofovir disoproxil fumarate
2005245296 Stable crystal of 4-oxoquinoline compound Japan Tobacco Inc. 22 Feb 2013      STRIBILD tenofovir disoproxil fumarate
2004251647 Abuse resistant amphetamine compounds Shire LLC 22 Jul 2013       VYVANSE lisdexamfetamine dimesilate
2005295394 Antibody formulation in histidine-acetate buffer Genentech, Inc. 06 May 2013        PERJETA pertuzumab
2008261137 Antibodies to OPGL Amgen Inc.; Amgen Fremont Inc. 07 Jun 2010        PROLIA denosumab

Applications Accepted

Patent No Title Applicant Reg Aprroval Date & Goods
696949 Cyclic hexapeptides having antibiotic activity Astellas Pharma Inc. MYCAMINE micafungin (as sodium)          Date extended 29/09/2020
752265 Stabilized pharmaceutical composition in lyophilized form Astellas Pharma Inc. MYCAMINE micafungin (as sodium)         Date extended 29/06/2025
781338 Peptides that lower blood glucose levels Zealand Pharma A/S LYXUMIA lixisenatide      Date extended 12/07/2025
729968 Quinazoline derivatives and pharmaceutical compositions containing them AstraZeneca AB CAPRELSA vandetanib    Date extended 23/09/2022
769222 Quinazoline derivatives as VEGF inhibitors AstraZeneca AB CAPRELSA vandetanib   Date extended 01/11/2025
2005282722 Pyridyl Inhibitors of Hedgehog Signalling Genentech, Inc.; Curis, Inc. ERIVEDGE vismodegib      09 May 2013
2007265246 Crystalline solvates and complexes of (IS) -1, 5-anhydro-L-C- (3- ( (phenyl) methyl) phenyl) -D-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes BRISTOL-MYERS SQUIBB COMPANY FORXIGA dapagliflozin    22 Oct 2012
2009217435 Xanthine derivative, production and use thereof as a medicament Boehringer Ingelheim Pharma GmbH & Co. KG TRAJENTA linagliptin

Extensions granted

No additional application(s) for Extension of Term have been granted under Section 76.

Surrendered and Revoked Letters Patent

Surrendered Letters Patent

No patents have been offered for surrender.

Revocation of Letters Patent

Patent No. Title Patentee Date of Patent
2011100848 Power monitoring system EMBERTEC PTY LTD 2 May 2013
2012100051 Online manager and employment offer recruitment solution JNN Consulting Group 4 July 2013
2002358713 Combination of cytochrome P450 dependent protease inhibitors Tibotec Pharmaceuticals Ltd. 4 July 2013
2013100794 Method and Apparatus for Converting Between Electrical and Mechanical Energy E.M.I.P. Pty Ltd 11 July 2013